BT has claimed its proposed £12.5 billion acquisition of mobile network operator EE will be good for competition, investment and innovation in the UK, with both consumers and businesses benefiting from it. And so BT has called on regulators to make a fast-track decision on its planned £12 billion takeover.
In a submission to the Competition and Markets Authority (CMA), which is currently looking into the deal, BT said that because the number of UK MNOs would remain at four after the acquisition.
It said that the ability of its mobile and landline rivals to compete using the Openreach network would not be affected, and said its broadband and mobile market shares would remain under the threshold at which regulatory action would be justified.
“A larger BT will be able to invest and innovate more than now, something that’s good for jobs and good for customers,” said BT CEO Gavin Patterson.
“The acquisition will lead to greater competition given our history as a natural and willing wholesaler, enabling other companies to use the networks we own.
Full content: The Guardian
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas